SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,264.51 330.92
( 0.43%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

314.5139046

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

39.09

49491.35

EPS(TTM)

Face Value()

Div & Yield %

49.9

0.31

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	161.03	91.26	62.80	32.32	21.46	21.76
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	161.03	91.26	62.80	32.32	21.46	21.76
Other Income	0.73	0.22	0.02	0.14	0.09	0.01
Stock Adjustments	20.76	-0.53	3.31	4.06	-0.06	0.12
Total Income	182.52	90.95	66.13	36.52	21.49	21.89
EXPENDITURE :
Raw Materials	116.94	61.78	49.59	22.83	17.69	18.86
Power & Fuel Cost	0.68	0.44	0.30	0.15	0.10	0.12
Employee Cost	13.90	7.98	6.22	3.31	1.15	2.06
Other Manufacturing Expenses	1.34	0.94	0.48	6.17	0.31	0.41
Selling & Administrative Expenses	27.74	5.90	4.53	2.59	1.32	1.24
Miscellaneous Expenses	1.81	0.94	0.33	0.05	0.03	0.02
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	162.41	77.99	61.45	35.10	20.60	22.70
Operating Profit	20.12	12.97	4.68	1.42	0.89	-0.82
Interest	2.02	1.80	1.03	0.43	0.69	0.79
Gross Profit	18.10	11.17	3.65	0.99	0.20	-1.61
Depreciation	2.22	1.17	0.67	0.29	0.28	0.28
Profit Before Tax	15.88	10.00	2.98	0.70	-0.08	-1.89
Tax	3.18	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.09	-0.02	0.10	0.07	0.03	0.05
Reported Net Profit	12.80	10.02	2.88	0.63	-0.11	-1.93
Extraordinary Items	-0.03	0.00	-0.02	0.02	0.00	0.00
Adjusted Net Profit	12.83	10.02	2.90	0.61	-0.11	-1.93
Adjustment below Net Profit	0.05	0.02	0.01	0.00	0.01	0.00
P & L Balance brought forward	-8.12	-18.17	-21.08	-21.71	-21.61	-19.68
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	4.73	-8.12	-18.19	-21.08	-21.71	-21.61
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	10.11	10.23	4.53	1.14	-0.34	-5.71
Earnings Per Share(Adj)-Unit Curr	10.11	10.23	4.53	1.14	-0.34	-5.71
Book Value-Unit Curr	78.94	43.16	20.73	15.75	11.86	12.16
Book Value(Adj)-Unit Curr	78.94	43.16	20.73	15.75	11.86	12.16

77,264.51 330.92 ( 0.43%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,369.62 237.64 (0.36%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)